Number of Shares
14,293.00
Current Holdings Value*
$346,610.00
% of Portfolio
1.61%
Total Estimate Gain
$116,743.68
% of Total Estimate Gain
44.78%

KENNEDY CAPITAL SMALL CAP VALUE FUND's Catalyst Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Investment Managers Series Trust II held 14,293.00 shares of Catalyst Pharmaceuticals Inc(CPRX), totaling $346,610.00. This investment constitutes 1.61% of their stock portfolio, and Investment Managers Series Trust II now holds 0.01% of the outstanding Catalyst Pharmaceuticals Inc(CPRX) stock.

The initial trade took place in 2023Q2. And since then KENNEDY CAPITAL SMALL CAP VALUE FUND has made 6 purchases of CPRX, at an average price of $14.40, for a total of 18,106.00 shares. In addition, there have been 2 sales at an average price of $20.19 for 3,813.00 shares. Based on historical transaction data and CPRX's current price of $21.02, KENNEDY CAPITAL SMALL CAP VALUE FUND's estimated gain on his CPRX holdings is $116,743.68, reflecting a 44.78% gain to date.

KENNEDY CAPITAL SMALL CAP VALUE FUND CPRX ($21.02) Holding Chart

KENNEDY CAPITAL SMALL CAP VALUE FUND CPRX ($21.02) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1